IL Receptor
Interleukin receptors (IL receptors) are a group of receptors that bind to interleukins, a family of cytokines that play essential roles in immune system regulation, inflammation, and hematopoiesis. Dysregulation of interleukin signaling is associated with various inflammatory and autoimmune diseases, making IL receptors critical targets for therapeutic intervention. IL receptor antagonists are being explored for the treatment of conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. At CymitQuimica, we offer a range of high-quality IL receptor modulators to support your research in cytokine signaling, immunology, and inflammatory disease therapy.
Found 113 products of "IL Receptor"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Spesolimab
CAS:<p>Spesolimab (BI 655130) is an antibody targeting IL-36 receptor, key in immunity, for systemic pustular psoriasis and dermatitis studies.</p>Purity:> 95%Color and Shape:LiquidMolecular weight:150 kDaNidanilimab
CAS:<p>Nidanilimab (CAN04) is an IL1RAP antibody with 1.10 pM affinity and antitumor effects on NSCLC and PDAC.</p>Purity:> 95%Color and Shape:SoildMolecular weight:150 kDaAmlexanox
CAS:<p>Amlexanox (AA673) treats ulcers by blocking leukotrienes, histamine, reducing inflammation, pain, and healing time.</p>Formula:C16H14N2O4Purity:99.67% - ≥95%Color and Shape:White Crystalline SolidMolecular weight:298.29BRD6989
CAS:<p>BRD6989, a cortistatin A analog, inhibits CDK8/19, enhances IL-10, and binds CDK8 with a 200 nM IC50.</p>Formula:C16H16N4Purity:99.43%Color and Shape:SolidMolecular weight:264.33Ixekizumab
CAS:<p>Ixekizumab: IgG4 antibody, neutralizes IL-17A (<3 pM), treats severe plaque psoriasis & arthritis.</p>Purity:98.86% (SEC-HPLC) - > 99.3% (SDS-PAGE); 95.4% (SEC-HPLC)Color and Shape:LiquidMolecular weight:146.2 kDaAbrezekimab
CAS:<p>Abrezekimab (VR 942), a humanized antibody, blocks IL-13/IL-13Rα1, for asthma/lung disease study.</p>Purity:98.34% (SEC-HPLC) - 98.34% (SEC-HPLC)Color and Shape:LiquidMolecular weight:48.1 kDaOlokizumab
CAS:<p>Revdofilimab (ABBV-368) is a human IgG monoclonal antibody targeting OX 40 with potential anticancer activity.</p>Purity:99% (SDS-PAGE); 98.3% (SEC-HPLC) - 99% (SDS-PAGE); 98.3% (SEC-HPLC)Color and Shape:LiquidBriakinumab
CAS:<p>Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the research of psoriasis multiple sclerosis.</p>Purity:>95%Color and Shape:LiquidElsilimomab
CAS:<p>Elsilimomab (B-E8) is a monoclonal antibody targeting IL-6, inhibiting the induction of bone marrow stromal cell senescence by dnmt3a mutation clones.</p>Purity:>95%Color and Shape:LiquidPerakizumab
CAS:<p>Perakizumab (RG4934) is a humanized monoclonal antibody targeting IL-17A, used in the study of psoriatic arthritis and other autoimmune diseases.</p>Purity:95.28% (SEC-HPLC) - 99.66% (SEC-HPLC)Color and Shape:LiquidMolecular weight:145.4 (kDa)Vobarilizumab
CAS:<p>Vobarilizumab (ALX-0061) is a humanized specific antibody targeting IL-6R and ALB, used in research on autoimmune diseases like rheumatoid arthritis.</p>Purity:>95%Color and Shape:LiquidIL-15-IN-1
CAS:<p>IL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).</p>Formula:C30H36N6O4SPurity:99.16%Color and Shape:SolidMolecular weight:576.71Dupilumab
CAS:<p>Dupilumab (REGN-668) is a systemic immunomodulator for AD.</p>Purity:95.00% - >99.2%Color and Shape:LiquidBermekimab
CAS:<p>Bermekimab (MABp1), an anti-interleukin-1α (IL-1α) monoclonal antibody.Bermekimab has potential anti-inflammatory activity to prevent skin inflammation.</p>Color and Shape:LiquidMolecular weight:145.45 kDaSarilumab
CAS:<p>Sarilumab: Potent IL-6 blocker, human antibody, reduces inflammation, treats rheumatoid arthritis.</p>Purity:97.4%Color and Shape:LiquidMolecular weight:144.12 kDaSiltuximab
CAS:<p>Siltuximab（CNTO-328） is a monoclonal antibody with anti-tumor activity targeting IL-6 for the study of giant lymph node hyperplasia (MCD) and COVID-19.</p>Purity:100% (SEC-HPLC) - > 95%Color and Shape:LiquidMolecular weight:144.98 kDaXeligekimab
CAS:<p>Xeligekimab (GR 1501) is a fully humanized monoclonal antibody that neutralizes IL-17A and has anti-inflammatory activity for the study of plaque psoriasis.</p>Purity:95%Color and Shape:LiquidRisankizumab
CAS:<p>Risankizumab (BI 655066) is a monoclonal antibody for psoriasis, targeting IL-23, with high affinity (Kd <10 pM) and an IC50 of 2 pM.</p>Purity:SDS-PAGE:95.3%;SEC-HPLC:98.3%Color and Shape:LiquidMolecular weight:145.85 kDaVunakizumab
CAS:<p>Vunakizumab is a humanized IgGκ monoclonal antibody targeting IL-17A, often linked to interleukin 22 to form Vunakizumab-IL22.</p>Purity:95%Color and Shape:LiquidPF-07038124 HCl
CAS:<p>PF-07038124 HCl is a selective and potent PDE4 inhibitor with an IC50 of 0.5 nM for PDE4B2.PF-07038124 HCl inhibits IL-13, IL-4, and IFNγ, and can be used in the study of skin disorders such as atopic dermatitis and plaque psoriasis.</p>Formula:C18H23BClNO4Purity:97.34% - 99.13%Color and Shape:SoildMolecular weight:363.64Olamkicept
CAS:<p>Olamkicept (FE-301) is a soluble gp130-Fc-fusion protein that inhibits interleukin 6 (IL-6) trans signaling.</p>Purity:98.2% (SDS-PAGE); 98.8% (SEC-HPLC) - 99.3% (SDS-PAGE); 97.6% (SEC-HPLC)Color and Shape:LiquidBrodalumab
CAS:<p>Brodalumab (AMG 827), a human IgG2 monoclonal antibody, inhibits IL-17R, treating psoriasis.</p>Purity:98.3%Color and Shape:LiquidMolecular weight:144.06 kDa2-Benzothiazolamine
CAS:<p>2-ABT: nitrogen-rich heterocycle used in drug synthesis, inhibits P450, with anti-inflammatory, anticonvulsant, anticancer properties.</p>Formula:C7H6N2SPurity:99.09% - 99.3%Color and Shape:Plates From Water Physical Description Odorless Gray To White Powder (Ntp 1992)Molecular weight:150.2Levilimab
CAS:<p>Levilimab (BCD-089) is a fully humanized human monoclonal antibody targeting membrane-bound and soluble IL-6 R for the study of rheumatoid arthritis.</p>Purity:97.8% (SDS-PAGE); 97.3% (SEC-HPLC) - 97.8% (SDS-PAGE); 97.3% (SEC-HPLC)Color and Shape:LiquidEnokizumab
CAS:<p>Enokizumab (MEDI-528) is a monoclonal antibody against interleukin IL-9. Enokizumab can be used to study asthma.</p>Purity:SDS-PAGE:95% SEC-HPLC:99.23%Color and Shape:LiquidMolecular weight:145.98 kDaMirikizumab
CAS:<p>Mirikizumab (LY3074828) is a humanized antibody targeting the p19 subunit of interleukin-23 (IL-23).</p>Purity:98.41% (SEC-HPLC) - 98.41% (SEC-HPLC)Color and Shape:LiquidOrdesekimab
CAS:<p>Ordesekimab (AMG 714) is a human anti-IL-15 IgG1 κ monoclonal antibody for studying NRCD.</p>Purity:> 95%Color and Shape:LiquidMolecular weight:145.12 kDaTildrakizumab
CAS:<p>Tildrakizumab (SCH 900222) is a humanized antibody against IL-23, with a 136 pM Kd, used for psoriasis research.</p>Purity:> 95%Color and Shape:LiquidMolecular weight:144.44 kDaYQ128
CAS:<p>YQ128 is a potent and selective inhibitor of second-generation NLRP3 (NOD-like receptor P3) inflammasome(IC50 of 0.30 µM), with anti-inflammatory activity.</p>Formula:C27H29ClN2O4S2Purity:99.89%Color and Shape:SolidMolecular weight:545.11Imsidolimab
CAS:<p>Imsidolimab (ANB 019) is a humanized anti-IL-36R monoclonal antibody that inhibits IL-36 signaling and can be used to study systemic pustular psoriasis.</p>Purity:99.1% (SDS-PAGE); 96.7% (SEC-HPLC) - 99.1% (SDS-PAGE); 96.7% (SEC-HPLC)Color and Shape:LiquidMyD88-IN-1
CAS:<p>MyD88-IN-1: Potent MyD88 inhibitor with anti-inflammatory effects, blocking NF-κB and TLR/IL-1 pathways; potential for cancer and inflammation treatment.</p>Formula:C23H24N6O7SPurity:>99.99%Color and Shape:SoildMolecular weight:528.54Ziltivekimab
CAS:<p>Ziltivekimab (MEDI 5117) is a CHO-expressed humanized monoclonal antibody targeting IL-6/IFNb2 for use in immune system diseases.</p>Purity:95% - 97.9% (SDS-PAGE); 97.3% (SEC-HPLC)Color and Shape:SoildTorudokimab
<p>Torudokimab (ZB-880) is a monoclonal antibody that neutralizes interleukin 33 and can be used to study immune system diseases.</p>Purity:95.8% (SDS-PAGE); 96.2% (SEC-HPLC) - 95.8% (SDS-PAGE); 96.2% (SEC-HPLC)Color and Shape:Odour LiquidHuMax-IL8
<p>HuMax-IL8 (MDX 018) is a humanized anti-IL-8 monoclonal antibody for the study of metastatic or unresectable solid tumors.</p>Purity:98.8% (SDS-PAGE); 97.4% (SEC-HPLC) - 98.8% (SDS-PAGE); 97.4% (SEC-HPLC)Color and Shape:Odour LiquidDaclizumab
CAS:<p>Daclizumab (Zenapax), a humanized antibody, blocks IL-2 by targeting CD25, used in multiple sclerosis.</p>Purity:SDS-PAGE:95% SEC-HPLC:99.99%Color and Shape:LiquidMolecular weight:144.12 kDaPascolizumab
CAS:<p>Pascolizumab (SB-240683) is a humanized monoclonal antibody against IL-4. Pascolizumab has asthmatic effects and can be used to study allergic rhinitis.</p>Purity:> 95%Color and Shape:LiquidMolecular weight:147.18 kDaNosantine racemate
CAS:<p>Nosantine racemate is the racemate of Nosantine which is a IL-2 inducer or enhancer of IL-2 induction by phytohemagglutinin (PHA).</p>Formula:C14H22N4O2Purity:98%Color and Shape:SolidMolecular weight:278.35Mepolizumab
CAS:<p>Mepolizumab (SB 240563) is a humanized monoclonal antibody neutralizing IL-5.</p>Purity:98% - 98%Color and Shape:LiquidGuselkumab
CAS:<p>Guselkumab (CNTO 1959) is a recombinant human IgG1 monoclonal antibody targeting the IL-23p19 subunit.</p>Purity:SDS-PAGE:95% SEC-HPLC:98.97%Color and Shape:LiquidMolecular weight:144.8 kDaDectrekumab
CAS:<p>Dectrekumab (QAX576) is a humanized monoclonal antibody targeting IL-13.</p>Purity:96.5% (SDS-PAGE); 97.1% (SEC-HPLC) - 96.5% (SDS-PAGE); 97.1% (SEC-HPLC)Color and Shape:LiquidCanakinumab
CAS:<p>Canakinumab: Human IL-1β antibody, anti-inflammatory, treats gout & coronary disease, IC50 of 43.6 pM (human), 40.8 pM (monkey).</p>Purity:98.8%Color and Shape:LiquidMolecular weight:145.18 kDaAnti-inflammatory agent 42
CAS:<p>Anti-inflammatory agent 42 has anti-inflammatory activity and inhibits the expression of TNF-α and IL-6 in LPS-stimulated macrophages.</p>Formula:C20H12N2OSPurity:98.13%Color and Shape:SolidMolecular weight:328.39Temtokibart
CAS:<p>Temtokibart is a humanized monoclonal antibody targeting IL22RA1, used in autoimmune and inflammatory disease research.</p>Color and Shape:LiquidMolecular weight:145.5PF-06342674
<p>PF-06342674 is a humanized monoclonal antibody targeting the IL-7 receptor-α, with immunoregulatory activity, used in Type 1 diabetes research.</p>Color and Shape:LiquidMolecular weight:145.5kDaMacrophage-activating lipopeptide 2 TFA
<p>Macrophage-activating lipopeptide 2 TFA (MALP-2 TFA) is a diacylglycerol lipopeptide and TLR-2/TLR-6 agonist activates immune cell responses macrophages,</p>Formula:C99H167N19O30S·xC2HF3O2Purity:97.56%Color and Shape:SolidMolecular weight:2135.56 (free base)Reslizumab
CAS:<p>Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG) 4 κ monoclonal antibody, thereby reducing eosinophil production and survival.</p>Purity:98.1% (SDS-PAGE); 98.6% (SEC-HPLC) - 98.1% (SDS-PAGE); 98.6% (SEC-HPLC)Color and Shape:LiquidMolecular weight:N/AABX-IL8
<p>ABX-IL8 is a humanized antibody targeting IL-8, capable of interfering with tube formation in human umbilical vein endothelial cells.</p>Purity:>95%Color and Shape:LiquidMolecular weight:145.5 kDaStapokibart
CAS:<p>Stapokibart (CM310) is a humanized monoclonal antibody targeting IL-4Rα, blocking IL-4Rα-mediated signaling. It is used in studies of atopic dermatitis.</p>Purity:96.09% (SEC-HPLC) - 96.09% (SEC-HPLC)Color and Shape:LiquidCNTO 607
<p>CNTO 607 (Anti-IL-13 Antibody) is a humanized antibody targeting IL-13, useful for studying inflammation.</p>Purity:98% (SDS-PAGE); 98.3% (SEC-HPLC) - 98% (SDS-PAGE); 98.3% (SEC-HPLC)Color and Shape:Odour LiquidY13g dihydrochloride
<p>Y13g dihydrochloride is a potent inhibitor of interleukin 6 (IL-6) and acetylcholinesterase (AChE) (both targets of Alzheimer's disease (AD) progression are</p>Formula:C16H25ClN2O4Purity:97.81%Color and Shape:SoildMolecular weight:344.83ABzOH
CAS:<p>2-(Cyclopropylethynyl)benzoic acid: NSAID-like, anti-inflammatory, anti-tumor, hinders cytokines and various cancers.</p>Formula:C12H10O2Purity:99.43%Color and Shape:SolidMolecular weight:186.21Anti-Mouse IL-4 Antibody (11B11)
<p>Anti-Mouse IL-4 Antibody (11B11) is an inhibitory antibody targeting mouse IL-4, with the clone number 11B11.</p>Purity:99%Color and Shape:Odour LiquidIL-17A antagonist 1
CAS:<p>IL-17A antagonist 1 is an IL-17A antagonist for the study of interleukin-related inflammatory and immune diseases.</p>Formula:C33H41FN6O4Purity:99.46%Color and Shape:SolidMolecular weight:604.71Anakinra
CAS:<p>Anakinra (Raleukin) is an antagonist of recombinant, nonglycosylated human IL-1R. It is the first biological agent to block the pro-inflammatory effects.</p>Formula:C759H1186N208O232S10Purity:95% - ≥95%Color and Shape:SolidMolecular weight:17257.6Anti-Human IL-17A
CAS:<p>Anti-Human IL-17A (Secukinumab H chain) is a human monoclonal antibody targeting IL-17A, offering high affinity and low immunogenicity for psoriasis.</p>Purity:98%Color and Shape:LiquidMolecular weight:151 kDaOssirene
CAS:<p>Ossirene (AS101), a potent in vitro and in vivo immunomodulator, is a novel inhibitor of IL-1beta converting enzyme.</p>Formula:C2H4Cl3O2Te·H4NPurity:≥98%Color and Shape:SolidMolecular weight:312.05RO2959 Hydrochloride
CAS:<p>RO2959 Hydrochloride (RO2959 HCl) is a potent and selective inhibitor of CRAC channel(IC50: 402 nM). It is also a potent inhibitor of human IL-2.</p>Formula:C21H20ClF2N5OSPurity:99.24%Color and Shape:SolidMolecular weight:463.93Apilimod mesylate
CAS:<p>Apilimod mesylate (STA 5326 mesylate) is a potent IL-12/IL-23 inhibitor.</p>Formula:C25H34N6O8S2Purity:99.51% - ≥95%Color and Shape:SolidMolecular weight:610.7CP 424174
CAS:<p>CP 424174 blocks IL-1β processing (IC50: 210 nM), halts mature IL-1β formation, limits NLRP3, and is effective orally in vivo.</p>Formula:C22H29ClN2O4SPurity:>99.99%Color and Shape:SolidMolecular weight:452.99Apilimod
CAS:<p>Apilimod (STA 5326) inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis.</p>Formula:C23H26N6O2Purity:99.38% - 99.89%Color and Shape:SolidMolecular weight:418.49VGX-1027
CAS:<p>VGX-1027 (GIT 27) is an isoxazole compound with various immunomodulatory properties.</p>Formula:C11H11NO3Purity:99.54% - 99.86%Color and Shape:SolidMolecular weight:205.21Secukinumab
CAS:<p>Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the</p>Purity:97.4% (SDS-PAGE); 98.3% (SEC-HPLC) - 99.10%Color and Shape:LiquidMolecular weight:147.93 kDaYM-90709
CAS:<p>YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.</p>Formula:C22H21N3O2Purity:>99.99%Color and Shape:SolidMolecular weight:359.42AX-024 hydrochloride
CAS:<p>AX-024 hydrochloride (AX-024 HCl) is an cytokine release inhibitor which can strongly inhibit the production of IL-6, TNFα, IFN-γ, IL-10 and IL-17A.</p>Formula:C21H23ClFNO2Purity:99.74%Color and Shape:SolidMolecular weight:375.87GSK717
CAS:<p>GSK717: potent, selective NOD2 inhibitor; disrupts NOD2/TLR2 synergy; no effect on NOD1, TNFR1, TLR2.</p>Formula:C28H28N4O2Purity:97.34% - 99.01%Color and Shape:SolidMolecular weight:452.55GIBH-130
CAS:<p>GIBH-130 markedly inhibits the IL-1β secretion by activated microglia (IC50: 3.4 nM). GIBH-130 is an effective inhibitor of neuroinflammation.</p>Formula:C20H20N6OPurity:99.52%Color and Shape:SolidMolecular weight:360.41Suplatast (Tosilate)
CAS:<p>Suplatast Tosilate (IPD 1151T) is a novel capsular anti-asthmatic drug. It ( IC50 above 100 μM) inhibits both IgE production, IL-4 and IL-5 synthesis.</p>Formula:C23H33NO7S2Purity:99.34% - 99.65%Color and Shape:White Or Off-White CrystalsMolecular weight:499.64IL-17A inhibitor 1
CAS:<p>IL-17A inhibitor 1 is a IL-17A inhibitor with IC50 of <9.45 nM in alphalisa assay. IL-17A inhibitor 1 inhibits HT-29 cells with IC50 of 9.3 nM.</p>Formula:C24H27F5N8O4Purity:99.37% - 99.37%Color and Shape:SolidMolecular weight:586.51Apilimod 2HCl
CAS:<p>Apilimod 2HCl (STA 5326 2HCl) is a PIKFYVE kinase inhibitor used in the study of amyotrophic lateral sclerosis.</p>Formula:C23H28Cl2N6O2Purity:98.41%Color and Shape:SolidMolecular weight:491.41Esonarimod
CAS:<p>Esonarimod (KE-298) is an antirheumatic drug.</p>Formula:C14H16O4SPurity:97.44%Color and Shape:SolidMolecular weight:280.34Dexamethasone Sodium Phosphate
CAS:<p>Dexamethasone Sodium Phosphate (Dexadreson) is a powerful anti-inflammatory and immunosuppressant synthetic glucocorticoid.</p>Formula:C22H30FO8P·2NaPurity:99.01% - 99.81%Color and Shape:SolidMolecular weight:516.4Clodronate disodium tetrahydrate
CAS:<p>Clodronate disodium tetrahydrate (Clastoban) inhibits bone resorption and soft tissue calcification.</p>Formula:CH10Cl2Na2O10P2Purity:98%Color and Shape:SolidMolecular weight:360.92Satralizumab
CAS:<p>Satralizumab (SA-237) is a humanized antibody targeting interleukin-6 (IL-6), used in research on neuromyelitis optica spectrum disorder (NMOSD).</p>Purity:95%Color and Shape:LiquidSirukumab
CAS:<p>Sirukumab (CNTO-136) is a humanized monoclonal antibody binding to IL-6, inhibiting IL-6-mediated signaling and transcription activator activation.</p>Purity:>95%Color and Shape:LiquidMolecular weight:144.6 (kDa)Brazikumab
CAS:<p>Brazikumab (AMG 139) is a humanized antibody targeting IL-23 by binding to the P19 subunit, a selective IL-23p19 antagonist.</p>Purity:98% (SDS-PAGE); 97.7% (SEC-HPLC) - 98% (SDS-PAGE); 97.7% (SEC-HPLC)Color and Shape:LiquidTirnovetmab
CAS:<p>Tirnovetmab (KIND-016) is a fully dog-derived monoclonal antibody targeting IL-31 with high affinity, suitable for investigating canine atopic dermatitis.</p>Purity:95% - 95%Color and Shape:LiquidGevokizumab
CAS:<p>Gevokizumab (S-78989) is a humanised monoclonal antibody targeting IL-1β, allosteric regulation, diabetes, cancer, inflammation, and cardiovascular diseases.</p>Purity:95%Color and Shape:LiquidPicankibart
CAS:<p>Picankibart (IBI112) is a human recombinant monoclonal antibody targeting IL-23p19, indicated for psoriasis treatment.</p>Purity:95% - 95%Color and Shape:LiquidCasdozokitug
CAS:<p>Casdozokitug is a human IgG1κ anti-IL-27 antibody that blocks immunosuppressive activity, relevant in tumor immunology and immune checkpoint therapy research.</p>Purity:95% - 95%Color and Shape:LiquidAnti-Mouse IL-6R Antibody (15A7)
<p>Anti-Mouse IL-6R Antibody (15A7) is an antibody inhibitor targeting mouse IL-6R, derived from rats, widely used in research and experiments</p>Purity:99% - 99%Color and Shape:Odour LiquidGumokimab
CAS:<p>Gumokimab (AK 111) is an anti-IL-17A mAb that blocks pro-inflammatory signaling, a candidate for psoriasis and ankylosing spondylitis.</p>Purity:95%Color and Shape:LiquidEbdarokimab
CAS:<p>Ebdarokimab (anti-IL-12/23 p40 mAb) inhibits the IL-12/IL-23 pathway and is under clinical investigation for SLE and plaque psoriasis.</p>Purity:95%Color and Shape:LiquidManfidokimab
CAS:<p>Manfidokimab is an anti-IL-4Rα mAb that blocks IL-4/IL-13 signaling, in trials for atopic dermatitis.</p>Purity:95%Color and Shape:LiquidInolimomab
CAS:<p>Inolimomab is a monoclonal antibody targeting CD25 (IL-2R α chain) for studying acute graft-versus-host disease (aGVHD).</p>Purity:95% - 95%Color and Shape:LiquidBempikibart
CAS:<p>Bempikibart (ADX-914) is a fully humanised monoclonal antibody targeting IL-7Rα, inhibiting IL-17 and TSLP (Thymic stromal lymphopoietin), inflammation.</p>Purity:95% - 95%Color and Shape:LiquidAnrukinzumab
CAS:<p>Anrukinzumab (IMA-638) is an anti-IL-13 mAb with anti-inflammatory effects, in development for ulcerative colitis and asthma.</p>Purity:95%Color and Shape:LiquidAfasevikumab
CAS:<p>Afasevikumab (RG 7624) is a fully humanised monoclonal antibody that targets and neutralises IL-17A and IL-17F,autoimmune diseases and inflammation.</p>Purity:95%Color and Shape:LiquidRademikibart
CAS:<p>Rademikibart (CBP-201) is a human monoclonal antibody selective for IL-4Rα, exhibiting strong affinity with a KD of 20.7 pM for human IL-4Rα epitopes, without</p>Purity:95%Color and Shape:LiquidBimekizumab
CAS:<p>Bimekizumab is a humanised monoclonal antibody targeting IL17A/IL17F, blocking inflammation-driven osteoblast differentiation.</p>Purity:>99.99%Color and Shape:LiquidZiralimumab
CAS:<p>Ziralimumab（ABX-RB2） is a monoclonal antibody that targets and inhibits IL-2 receptor, thereby modulating the immune response.</p>Purity:95%Color and Shape:LiquidLebrikizumab
CAS:<p>Lebrikizumab is a humanised monoclonal antibody that targets and inhibits interleukin 13 (IL-13), suppressing Th2 inflammation.asthma and atopic dermatitis.</p>Purity:95%Color and Shape:LiquidLusvertikimab
CAS:<p>Lusvertikimab (OSE-127) is a humanized anti-IL7R antibody with anti-leukemic efficacy and can be used to study leukemia.</p>Purity:95% - 98.4% (SDS-PAGE); 99% (SEC-HPLC)Color and Shape:LiquidEtokimab
CAS:<p>Etokimab (ANB-020) is a humanised monoclonal antibody targeting IL-33, neutrophil migration, atopic dermatitis, asthma, and sinusitis.</p>Purity:95%Color and Shape:LiquidD228
CAS:<p>D228 is an oral anti-inflammatory,inhibi B and T lymphocytes, down-regulation of MyD88/TRAF6/p38 and up-regulation of IL-10,inflammatory bowel disease (IBD).</p>Formula:C22H28O12Purity:99.91%Color and Shape:SolidMolecular weight:484.45Vopikitug
CAS:<p>Vopikitug is a humanized monoclonal antibody targeting IL-2RA with antitumor activity. It can be used to study cancer.</p>Purity:99.1% (SDS-PAGE); 96.5% (SEC-HPLC) - 99.1% (SDS-PAGE); 96.5% (SEC-HPLC)Color and Shape:LiquidA-802715
CAS:<p>A-802715 is a novel methylxanthine derivative that decreases the endogenous formation and blood levels of pro-inflammatory substances and increases the</p>Formula:C16H26N4O3Purity:96.29%Color and Shape:SolidMolecular weight:322.4BI605906
CAS:<p>BI605906 is an IKKβ inhibitor that can be used to study inflammatory skin diseases such as psoriasis.</p>Formula:C17H22F2N4O3S2Purity:97.14%Color and Shape:SolidMolecular weight:432.51IL-4-inhibitor-1
CAS:<p>IL-4 inhibitor: Binds IL-4 (Kd=1.8 μM), blocks activity (EC50=1.81 μM), selective vs. IL-13, stops IL-4-JAK1-STAT6 in THP-1 monocytes (EC50=3.1 μM).</p>Formula:C18H12FN3O2Purity:98.78% - 99.53%Color and Shape:SolidMolecular weight:321.31LMT-28
CAS:<p>LMT-28 is an inhibitor of IL-6 and selectively inhibits IL-6-induced phosphorylation of gp130, STAT3, and JAK2.</p>Formula:C17H29NO4Purity:99.88%Color and Shape:SolidMolecular weight:311.42Resiniferatoxin
CAS:<p>Resiniferatoxin ((+)-Resiniferatoxin) is a highly potent synthetic TRPV1 agonist.Cost-effective and quality-assured.</p>Formula:C37H40O9Purity:93.08% - 99.34%Color and Shape:SolidMolecular weight:628.71
